#702 — The Industry Wire

  1. FDA misses review deadline for genetic drug candidate.
  2. Supreme Court sides with HHS on hospital payments.
  3. Tenet to continue M&A for ambulatory surgery centers
  4. C-suite compensation grew 20% in 2024
  5. FDA ruling ends era of compounded GLP-1 weight-loss drugs.
  6. Humana to shore up Medicare Advantage business
  7. Penn. bill would legalize OTC ivermectin sales
  8. GOP senator calls for reversal of federal research cuts.
  9. FDA debates whether to approve seasonal COVID shots.
  10. RFK Jr.: Don’t flush unused medications
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Imaging Wire team

You're all set!